First line chemotherapy of metastatic breast cancer

P. Pronzato, M. Rondini

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

In the last 20-30 years the approach to metastatic breast cancer by chemotherapy has been largely studied. Anthracyclines, taxanes and, more recently, capecitabine and gemcitabine represent the breakthrough of treatment. In the next future the combination of chemotherapy and target therapy will be considered more frequently.

Original languageEnglish
JournalAnnals of Oncology
Volume17
Issue numberSUPPL. 5
DOIs
Publication statusPublished - May 2006

Fingerprint

gemcitabine
Breast Neoplasms
Drug Therapy
Taxoids
Anthracyclines
Combination Drug Therapy
Therapeutics
Capecitabine

Keywords

  • Chemotherapy
  • Metastatic breast cancer
  • Trastuzumab

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

First line chemotherapy of metastatic breast cancer. / Pronzato, P.; Rondini, M.

In: Annals of Oncology, Vol. 17, No. SUPPL. 5, 05.2006.

Research output: Contribution to journalArticle

Pronzato, P. ; Rondini, M. / First line chemotherapy of metastatic breast cancer. In: Annals of Oncology. 2006 ; Vol. 17, No. SUPPL. 5.
@article{ed6760899dcd4309b51a263974e77ec7,
title = "First line chemotherapy of metastatic breast cancer",
abstract = "In the last 20-30 years the approach to metastatic breast cancer by chemotherapy has been largely studied. Anthracyclines, taxanes and, more recently, capecitabine and gemcitabine represent the breakthrough of treatment. In the next future the combination of chemotherapy and target therapy will be considered more frequently.",
keywords = "Chemotherapy, Metastatic breast cancer, Trastuzumab",
author = "P. Pronzato and M. Rondini",
year = "2006",
month = "5",
doi = "10.1093/annonc/mdj974",
language = "English",
volume = "17",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "SUPPL. 5",

}

TY - JOUR

T1 - First line chemotherapy of metastatic breast cancer

AU - Pronzato, P.

AU - Rondini, M.

PY - 2006/5

Y1 - 2006/5

N2 - In the last 20-30 years the approach to metastatic breast cancer by chemotherapy has been largely studied. Anthracyclines, taxanes and, more recently, capecitabine and gemcitabine represent the breakthrough of treatment. In the next future the combination of chemotherapy and target therapy will be considered more frequently.

AB - In the last 20-30 years the approach to metastatic breast cancer by chemotherapy has been largely studied. Anthracyclines, taxanes and, more recently, capecitabine and gemcitabine represent the breakthrough of treatment. In the next future the combination of chemotherapy and target therapy will be considered more frequently.

KW - Chemotherapy

KW - Metastatic breast cancer

KW - Trastuzumab

UR - http://www.scopus.com/inward/record.url?scp=33745594833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745594833&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdj974

DO - 10.1093/annonc/mdj974

M3 - Article

VL - 17

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - SUPPL. 5

ER -